NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Neuralstem, Inc. (AMEX: CUR)

 
CUR Technical Analysis
4
As on 31st Oct 2017 CUR Share Price closed @ 1.21 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 3.16 & Sell for SHORT-TERM with Stoploss of 1.26 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

CUR Share Price

Open 1.24 Change Price %
High 1.26 1 Day -0.03 -2.42
Low 1.20 1 Week 0.00 0.00
Close 1.21 1 Month -0.14 -10.37
Volume 147860 1 Year 0.93 332.14
52 Week High 6.60 | 52 Week Low 0.23
 
AMEX USA Most Active Stocks
PAL 0.05 -50.00%
NGD 3.29 -6.80%
RBY 0.03 -70.00%
LODE 0.12 -7.69%
PBTH 8.23 0.37%
GGR 0.02 100.00%
VTG 0.05 -16.67%
SYRG 8.13 0.87%
GSX 0.02 0.00%
SHZ 0.10 -16.67%
 
AMEX USA Top Gainers Stocks
GGR 0.02 100.00%
ATC 0.37 60.87%
ATC 0.37 60.87%
ATC 0.37 60.87%
ATC 0.37 60.87%
MBA 0.20 25.00%
MBA 0.20 25.00%
MBA 0.20 25.00%
IG 7.68 22.49%
IG 7.68 22.49%
 
AMEX USA Top Losers Stocks
RBY 0.03 -70.00%
PAL 0.05 -50.00%
PAL 0.05 -50.00%
PAL 0.05 -50.00%
QBC 0.20 -33.33%
LBY 6.84 -25.33%
ATL 0.06 -25.00%
ATL 0.06 -25.00%
SNT 0.12 -20.00%
INV 0.14 -17.65%
 
 
CUR
Daily Charts
CUR
Intraday Charts
Whats New @
Bazaartrend
CUR
Free Analysis
 
CUR Important Levels Intraday
SUPPORT0.00
SUPPORT0.00
RESISTANCE1.27
RESISTANCE1.24
SUPPORT1.18
SUPPORT1.15
SUPPORT0.00
SUPPORT0.00
 
CUR Target for Month October
4th UP TARGET2
3rd UP TARGET1.75
2nd UP TARGET1.59
1st UP TARGET1.43
1st DOWN TARGET0.99
2nd DOWN TARGET0.83
3rd DOWN TARGET0.67
4th DOWN TARGET0.42
 
CUR Weekly Target
4th UP TARGET0.00
3rd UP TARGET0.00
2nd UP TARGET0.00
1st UP TARGET0.00
1st DOWN TARGET0.00
2nd DOWN TARGET0.00
3rd DOWN TARGET0.00
4th DOWN TARGET0.00
 
CUR Target for Year 2020
4th UP TARGET0
3rd UP TARGET0
2nd UP TARGET0
1st UP TARGET0
1st DOWN TARGET0
2nd DOWN TARGET0
3rd DOWN TARGET0
4th DOWN TARGET0
 
 
CUR Other Details
Segment EQ
Market Capital 64654812.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
CUR Address
CUR
9700 Great Seneca Highway
Rockville, MD 20850
United States
Phone: 301-366-4841
 
CUR Latest News
 
Your Comments and Response on Neuralstem, Inc.
 
CUR Business Profile
Neuralstem, Inc., a biopharmaceutical company, focuses on the development and commercialization of treatments for central nervous system disease based on human neural stem cells and the use of small molecule compounds. The company’s stem cell technology enables the isolation and expansion of human neural stem cells from various areas of the developing human brain and spinal cord enabling the generation of physiologically relevant human neurons of various types. Its clinical program products include NSI–566, which is in Phase II clinical trials for the treatment of amyotrophic lateral sclerosis, and Phase I clinical trials for chronic spinal cord injury. The company’s clinical development products also comprise NSI–566 that is in Phase I/II clinical trials for motor deficits due to ischemic stroke in China; and NSI–189 that is in Phase Ib for the treatment of major depressive disorders. Neuralstem, Inc. was founded in 1996 and is headquartered in Rockville, Maryland.
 
2005-2019 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service